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ABSTRACT
Objective To develop and validate a new diabetes risk
algorithm (the QDScore) for estimating 10 year risk of
acquiring diagnosed type 2 diabetes over a 10 year time
period in an ethnically and socioeconomically diverse
population.
Design Prospective open cohort study using routinely
collected data from 355 general practices in England and
Wales to develop the score and from 176 separate
practices to validate the score.
Participants 2540753 patients aged 25-79 in the
derivation cohort, who contributed 16436135 person
years of observation and of whom 78081 had an incident
diagnosis of type 2 diabetes; 1232832 patients
(7643037 person years) in the validation cohort, with
37535 incident cases of type 2 diabetes.
Outcome measures A Cox proportional hazards model
was used to estimate effects of risk factors in the
derivation cohort and to derive a risk equation inmen and
women. The predictive variables examined and included
in the final model were self assigned ethnicity, age, sex,
body mass index, smoking status, family history of
diabetes, Townsend deprivation score, treated
hypertension, cardiovascular disease, and current use of
corticosteroids; the outcome of interest was incident
diabetes recorded in general practice records. Measures
of calibration and discrimination were calculated in the
validation cohort.
Results A fourfold to fivefold variation in risk of type 2
diabetes existed between different ethnic groups.
Compared with the white reference group, the adjusted
hazard ratio was 4.07 (95% confidence interval 3.24 to
5.11) for Bangladeshi women, 4.53 (3.67 to 5.59) for
Bangladeshi men, 2.15 (1.84 to 2.52) for Pakistani
women, and 2.54 (2.20 to 2.93) for Pakistani men.
Pakistani and Bangladeshi men had significantly higher
hazard ratios than Indian men. Black African men and
Chinese women had an increased risk compared with the
corresponding white reference group. In the validation
dataset, the model explained 51.53% (95% confidence
interval 50.90 to 52.16) of the variation in women and
48.16% (47.52 to 48.80) of that in men. The risk score
showed good discrimination, with a D statistic of 2.11
(95%confidence interval 2.08 to2.14) inwomenand1.97
(1.95 to 2.00) in men. The model was well calibrated.
Conclusions The QDScore is the first risk prediction
algorithm to estimate the 10 year risk of diabetes on the
basis of a prospective cohort study and including both
social deprivation and ethnicity. The algorithm does not
need laboratory tests and can be used in clinical settings
and also by the public through a simple web calculator
(www.qdscore.org).
INTRODUCTION
The prevalence of type 2 diabetes and the burden of
disease caused by it have increased very rapidly
worldwide.1 This has been fuelled by ageing
populations,2 poor diet,3 and the concurrent epidemic of
obesity.45Thehealth andeconomic consequencesof this
diabetes epidemic are huge and rising.6 Strong evidence
from randomised controlled trials shows that beha-
vioural or pharmacological interventions can prevent
type 2 diabetes in up to two thirds of high risk cases.7-10
Cost effectiveness modelling suggests that screening
programmes aid earlier diagnosis and help to prevent
type 2 diabetes or improve outcomes in people who
develop the condition,1112 making the prevention and
early detection of diabetes an international public health
priority.1314 Early detection is important, as up to half of
peoplewithnewlydiagnosed type2diabeteshaveoneor
more complications at the time of diagnosis.15
Although several algorithms forpredicting the riskof
type 2 diabetes have been developed,16-19 no widely
accepted diabetes risk prediction score has been
developed and validated for use in routine clinical
practice. Previous studies have been limited by size,16
and some have performed inadequately when tested in
ethnically diverse populations.20 A new diabetes risk
prediction tool with appropriate weightings for both
social deprivation and ethnicity is needed given the
prevalence of type 2 diabetes, particularly among
minority ethnic communities, appreciable numbers of
whom remain without a diagnosis for long periods of
time.21 Such patients have an increased risk of
avoidable morbidity and mortality.22
We present the derivation and validation of a new
risk prediction algorithm for assessing the risk of
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developing type 2 diabetes among a very large and
unselected population derived from family practice,
with appropriate weightings for ethnicity and social
deprivation.Wedesigned thealgorithm(theQDScore)
so that it would be based on variables that are readily
available inpatients’ electronichealth recordsorwhich
patients themselves would be likely to know—that is,
without needing laboratory tests or clinical measure-
ments—thereby enabling it to be readily and cost
effectively implemented in routine clinical practice and
by national screening initiatives.
METHODS
Study design and data source
Wedid aprospective cohort study in a largepopulation
of primary care patients from version 19 of the
QResearch database (www.qresearch.org). This is a
large, validated primary care electronic database
containing the health records of 11 million patients
registered with 551 general practices using the Egton
Medical Information System (EMIS) computer sys-
tem. Practices and patients contained on the database
are nationally representative for England and Wales
and similar to those on other large national primary
care databases using other clinical software systems.23
Practice selection
We included all QResearch practices in England and
Wales once they had been using their current EMIS
system for at least a year, so as to ensure completeness
of recording of morbidity and prescribing data. We
randomly allocated two thirds of practices to the
derivation dataset and the remaining third to the
validation dataset; we used the simple random
sampling utility in Stata to assign practices to the
derivation or validation cohort.
Cohort selection
We identified an open cohort of patients aged
25-79 years at the study entry date, drawn from patients
registered with eligible practices during the 15 years
between1 January1993and31March2008.Weusedan
opencohortdesign, rather thanaclosedcohortdesign,as
this allows patients to enter the population throughout
thewhole studyperiod rather than requiring registration
ona fixeddate;ourcohort should thus reflect the realities
of routine clinical practice. We excluded patients with a
prior recorded diagnosis of diabetes (type 1 or 2),
temporary residents, patientswith interruptedperiods of
registrationwith thepractice, and thosewhodidnothave
a valid postcode related Townsend deprivation score
(about 4% of the population).
For each patient, we determined an entry date to the
cohort, which was the latest of their 25th birthday, their
date of registration with the practice, the date on which
thepractice computer systemwas installedplusoneyear,
and the beginning of the study period (1 January 1993).
We included patients in the analysis once they had a
Table 1 | Characteristics of patients aged 25-79 free of diabetes at baseline in derivation and validation cohorts between 1993
and 2008. Values are numbers (percentages) unless stated otherwise
Characteristic
Derivation cohort Validation cohort
Women Men Women Men
No of patients 1 283 135 1 257 618 622 488 610 344
Total person years’ observation 8 373 101 8 063 034 3 898 407 3 744 630
No of incident cases of type 2 diabetes 34 916 43 165 16 912 20 623
Mean (SD) Townsend score −0.19 (3.4) −0.12 (3.4) −0.15 (3.5) −0.32 (3.6)
Median (interquartile range) age (years) 41 (31-56) 41 (32-54) 42 (32-56) 41 (32-54)
Ethnicity:
White or not recorded 1 240 470 (96.67) 1 220 355 (97.04) 600 454 (96.46) 589 570 (96.60)
Indian 6 713 (0.52) 6 544 (0.52) 4 044 (0.65) 4 255 (0.70)
Pakistani 4 097 (0.32) 4 707 (0.37) 1 696 (0.27) 1 874 (0.31)
Bangladeshi 1 557 (0.12) 1 876 (0.15) 2 078 (0.33) 2 745 (0.45)
Other Asian 4 075 (0.32) 3 322 (0.26) 1 908 (0.31) 1 477 (0.24)
Black Caribbean 6 014 (0.47) 4 416 (0.35) 2 632 (0.42) 2 020 (0.33)
Black African 9 362 (0.73) 7 695 (0.61) 3 762 (0.60) 3 336 (0.55)
Chinese 2 619 (0.20) 1 709 (0.14) 1 435 (0.23) 948 (0.16)
Other, including mixed 8 228 (0.64) 6 994 (0.56) 4 479 (0.72) 4 119(0.67)
Risk factors:
Ethnicity recorded 339 209 (26.44) 278 920 (22.18) 153 634 (24.68) 126 698 (20.76)
Body mass index recorded 1 013 326 (78.97) 895 308 (71.19) 498 397 (80.07) 440 159 (72.12)
Smoking recorded 1 154 858 (90.00) 1 046 823 (83.24) 566 602 (91.02) 514 693 (84.33)
Body mass index and smoking recorded 1 001 291 (78.03) 881 796 (70.12) 491 952 (79.03) 432 406 (70.85)
Family history of diabetes 148 466 (11.57) 102 583 (8.16) 68 500 (11.00) 47 569 (7.79)
Current smoker 298 455 (23.26) 349 294 (27.77) 149 492 (24.02) 173 076 (28.36)
Treated hypertension 74 436 (5.80) 60 232 (4.79) 39 174 (6.29) 32 131 (5.26)
Cardiovascular disease 32 447 (2.53) 51 601 (4.10) 16 975 (2.73) 27 222 (4.46)
Corticosteroids at baseline 22 424 (1.75) 14 738 (1.17) 12 721 (2.04) 8 190 (1.34)
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minimum of one year’s complete data in their medical
record.24 For each patient, we determined the right
censordate,whichwas theearliestof thedateofdiagnosis
of type 2 diabetes, date of death, date of deregistration
with the practice, date of last upload of computerised
data, or the study end date (31 March 2008).
Primary outcomes
Our primary outcome measure was the first (incident)
diagnosis of type 2 diabetesmellitus as recorded on the
general practice computer records. We identified
patients with diabetes by searching the electronic
health record for a diagnosis Read code for diabetes
(C10%). As in other studies, we classified patients as
having type 1 diabetes if they had a diagnosis of
diabetes and had been prescribed insulin under the age
of 35 and classified the remaining patients as having
type 2 diabetes.25
Diabetes risk factors
We examined the following variables for inclusion in
our analysis, all of which are knownor thought to affect
risk of developing diabetes,16-19 26-29 and are also likely
tobe recorded in thepatients’ electronic records as part
of routine clinical practice: self assigned ethnicity (nine
categories); age at study entry (in single years); body
mass index (continuous); smoking status (current
smoker, not a current smoker); Townsend deprivation
score (2001 census data evaluated at output areas as a
continuous variable) ranging from −6 in the most
affluent to 11 in the most deprived; recorded family
history of diabetes in a first degree relative (binary
variable yes/no); diagnosis of cardiovascular disease at
baseline (binary variable yes/no); treatedhypertension
at baseline—that is, diagnosis of hypertension plus
more than twoprescriptions for antihypertensivedrugs
(binary variable yes/no); systemic corticosteroids at
baseline—that is, at least two prescriptions within the
preceding six months (binary variable yes/no).
We restricted all values of these variables to those
that had been recorded in the person’s electronic
healthcare record before the diagnosis of type 2
diabetes (or before censoring for those who did not
develop type 2 diabetes). We used Read codes for
ethnicity to denote self assigned ethnicity. The Read
classification is the coding system in use in general
practice in England and Wales (ICD-10 is the
equivalent coding system in use in hospitals). We
grouped the codes into the English National Health
Service standard 16+1 categories for the initial
descriptive analysis. We then combined these 16+1
categories into the final nine reporting groups, thereby
ensuring sufficient numbers of events in each group to
enable a meaningful analysis. The “white or not
recorded” category comprised British, Irish, and
other white background, as well as those whose
ethnicity was not recorded. We designated this as the
reference category.We combined the group for whom
ethnicitywas not recordedwith thewhite ethnic group;
assuming the study population is comparable to the
United Kingdom population, 93% or more of people
without ethnicity recorded would be expected to be
fromawhite ethnic group. The “other includingmixed
category” comprised “white and black Caribbean,”
“white and black African,” “white and Asian,” “other
mixed,” “other black, and other ethnic group.” The
“other Asian” category included Read codes for East
AfricanAsian, Indo-Caribbean, Punjabi, Kashmiri, Sri
Lankan, Tamil, Sinhalese, Caribbean Asian, British
Asian, mixed Asian, or Asian unspecified.
Forbodymass indexand smoking status,weused the
values recordedclosest to the studyentrydate.Weused
body mass index rather than waist circumference, as
the latter is not well recorded on clinical computer
systems in the UK.
Model derivation and development
We calculated crude incidence rates of type 2 diabetes
according to age, ethnic group, and deprivation in
fifths. We then directly age standardised the incidence
rates by ethnic group and deprivation by using the age
distribution in five year bands of the entire derivation
cohort as the standard population. We also used the
same method to age standardise the means of
Table 2 | Characteristics of men and women in derivation cohort with and without complete data for body mass index and smoking. Values are numbers
(percentages) unless stated otherwise
Body mass index Smoking status
Women with
missing data
Women with
complete data
Men with
missing data
Men with
complete data
Women with
missing data
Women with
complete data
Men with
missing data
Men with
complete data
No of patients 269 809 1 013 326 362 310 895 308 128 277 1 154 858 210 795 1 046 823
Mean (SD) Townsend score 0.19 (3.5) −0.3 (3.4) 0.21 (3.5) −0.25 (3.4) 0.39 (3.5) −0.26 (3.4) 0.4 (3.5) −0.22 (3.4)
Mean (SD) age 45 (17) 45 (15) 42 (14) 44 (14) 46 (17) 45 (15) 42 (14) 44 (14)
Mean (SD) body mass index NA 25 (4.8) NA 26 (4) 26 (5) 25 (4.8) 26 (4.2) 26 (4)
Family history of diabetes 9 884 (3.66) 138 582 (13.68) 7497 (2.07) 95 086 (10.62) 2 189 (1.71) 146 277 (12.67) 2450 (1.16) 100 133 (9.57)
Current smoker 42 483 (15.75) 255 972 (25.26) 61 714 (17.03) 287 580 (32.12) NA 298 455 (25.84) NA 349 294 (33.37)
Treated hypertension 8 368 (3.10) 66 068 (6.52) 5 740 (1.58) 54 492 (6.09) 2 500 (1.95) 71 936 (6.23) 2 067 (0.98) 58 165 (5.56)
Cardiovascular disease 5 829 (2.16) 26 618 (2.63) 7 030 (1.94) 44 571 (4.98) 2 288 (1.78) 30 159 (2.61) 3 025 (1.44) 48 576 (4.64)
Corticosteroids at baseline 3 376 (1.25) 18 688 (1.84) 2 521 (0.70) 12 217 (1.36) 1 380 (1.08) 21 044 (1.82) 1 044 (0.50) 13 694 (1.31)
% (95% CI) observed risk of
diabetes at 10 years
5.29 (5.15 to
5.44)
3.95 (3.89 to
4.00)
3.86 (3.76 to
3.96)
5.78 (5.71 to
5.85)
6.73 (6.46 to
7.01)
4.00 (3.95 to
4.06)
3.98 (3.84 to
4.13)
5.50 (5.44 to
5.56)
NA=not applicable.
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continuous variables and proportions with risk factors
by ethnic group.
We used a Cox proportional hazards model in the
derivation dataset to estimate the coefficients and
hazard ratios associated with each potential risk factor
for the first ever recorded diagnosis of diabetes formen
and women separately. As in a previous study,30 we
used the Bayes information criterion to compare
models.31 This is a likelihood measure in which lower
values indicate better fit and in which a penalty is paid
for increasing thenumberofvariables in themodel.We
used fractional polynomials to model non-linear risk
relations with continuous variables where
appropriate.32 33 We tested for interactions between
each variable and age and between smoking and
deprivation and included significant interactions in the
final model. Continuous variables were centred for
analysis.
We used multiple imputation to replace missing
values for smoking status and bodymass index, andwe
used these values in our main analyses. We fitted our
finalmodelon thebasisofmultiply imputeddatasetsby
using Rubin’s rules to combine estimates of effects and
standard errors of estimates to allow for the uncertainty
caused by missing data.34 Multiple imputation is a
statistical technique designed to reduce the biases that
can occur in “complete case” analysis along with a
substantial loss of power and precision.35-37 The
imputation technique involves creatingmultiple copies
of the data and replaces missing values with imputed
values on the basis of a suitable random sample from
their predicteddistribution.Multiple imputation there-
fore allows patients with incomplete data to still be
included in analyses, thereby making full use of all the
available data, and thus increasing power and preci-
sion, butwithout compromisingvalidity.38Weused the
ICE procedure in Stata to obtain five imputed datasets
(further details are available from the corresponding
author).39
We took the regression coefficient (that is, the log of
the hazard ratio) for each variable from the final model
and used these as weights for the new disease risk
equations for type 2 diabetes. We combined these
weights with the baseline survivor function for
diagnosis of diabetes evaluated at 10 years and centred
on the means of continuous risk factors to derive a risk
equation for 10 years’ follow-up. We have presented
the Townsend coefficients in standard deviation units
so that this can be applied in a non-UK setting where
other indices of deprivation might apply.
We compared our final model (model A) with three
other models in order to determine the additional
contribution to the fit (using the Bayes information
criterion in which lower values indicate better fit) and
performance of the model of including both ethnicity
and deprivation in the algorithm.Our first supplemen-
tary model (model B) included all the variables except
for deprivation and ethnicity, the secondmodel (model
C) included deprivation but not ethnicity, and the third
(model D) included ethnicity but not deprivation.
Validation of the QDScore
We tested the performance of the final algorithm (the
QDScore) in the validation dataset. We calculated the
10 year estimated risk of acquiring type 2 diabetes for
each patient in the validation dataset by usingmultiple
imputations to replace missing values for smoking
status andbodymass index, as in thederivationdataset.
We calculated the mean predicted risk and the
observed risk of diabetes at 10 years and compared
these by 10th of predicted risk. The observed risk at
10 years was obtained by using the 10 year Kaplan-
Meier estimate. We calculated the Brier score (a
measure of goodness of fit where lower values indicate
better accuracy40) by using the censoring adjusted
Table 3 | Crude and age standardised incidence of type 2 diabetes per 1000 person years by sex, deprivation fifth, and ethnicity in derivation dataset
Women Men
Person years Crude rate Age standardised rate (95% CI) Person years Crude rate Age standardised rate (95% CI)
Townsend fifth
1 (most affluent) 2 080 246 3.07 3.00 (2.93 to 3.08) 1 958 014 4.86 4.48 (4.39 to 4.57)
2 1 789 575 3.52 3.44 (3.35 to 3.52) 1 696 345 5.16 4.88 (4.78 to 4.98)
3 1 669 677 4.25 4.19 (4.09 to 4.29) 1 591 842 5.56 5.54 (5.43 to 5.66)
4 1 553 816 5.03 5.17 (5.05 to 5.28) 1 511 807 5.74 6.15 (6.02 to 6.28)
5 (most deprived) 1 259 406 5.81 6.39 (6.25 to 6.54) 1 286 781 5.73 6.56 (6.41 to 6.71)
Ethnicity
White/not recorded 8 176 581 4.16 4.13 (4.08 to 4.17) 7 900 533 5.33 5.31 (5.26 to 5.36)
Indian 31 535 6.41 7.90 (6.73 to 9.08) 28 127 8.64 9.60 (8.35 to 10.85)
Pakistani 18 735 8.49 11.19 (9.16 to 13.21) 19 634 9.88 13.22 (11.24 to 15.21)
Bangladeshi 6 683 11.37 18.20 (12.93 to 23.47) 6 944 12.82 19.34 (14.28 to 24.4)
Other Asian 13 056 3.45 6.08 (2.73 to 9.44) 9 588 7.09 8.09 (6.03 to 10.15)
Caribbean 36 205 5.72 7.35 (6.28 to 8.43) 25 431 6.96 6.97 (5.89 to 8.05)
Black African 28 670 3.52 5.99 (4.54 to 7.44) 23 025 5.43 8.77 (6.84 to 10.7)
Chinese 9 547 3.35 5.40 (3.2 to 7.6) 6 603 3.33 3.32 (1.87 to 4.78)
Other 31 708 3.56 5.91 (4.51 to 7.3) 24 904 5.02 6.84 (5.51 to 8.18)
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version adapted for survival data,41 D statistic (a
measure of discrimination where higher values indi-
cate better discrimination),42 and an R2 statistic (a
measure of explainedvariation for survival data,where
higher values indicate that more variation is
explained).43 We also calculated the area under the
receiver operator curve, where higher values indicate
better discrimination. We also compared the perfor-
mance of the QDScore with the Cambridge risk
score,16 which includes age, sex, body mass index,
smoking status, corticosteroids, antihypertensive treat-
ment, and family history of diabetes.
We calculated the proportion of patients in the
validation sample who had an estimated 10 year risk of
diagnosed diabetes of ≥10%, ≥15%, ≥20%, ≥30%,
≥40%, and ≥50% by age, sex, ethnic group, and
deprivation according to the QDScore.
We used all the available data on the QResearch
database and therefore did not do a pre-study sample
size calculation. We used Stata (version 10) for all
analyses and chose a significance level of 0.01 (two
tailed).
RESULTS
Description of the derivation and validation dataset
Overall, 531UKpracticesmet our inclusion criteria, of
which 355 were randomly assigned to the derivation
dataset and 176 to the validation dataset.We excluded
20 practices: four practices had not completely
uploaded all their electronic data for the relevant
study period, seven practices were from Scotland, and
nine practices were from Northern Ireland.
The derivation cohort contained 2 594 578 patients,
ofwhom53 825had type1or type2diabetes before the
start of the study and were therefore excluded leaving
2 540 753 patients (1 283 135; 50.50% women) aged
25-79 years and free of diabetes at baseline for analysis.
The validation cohort contained 1 261 419 patients
aged25-79,ofwhom28 587hadapreviousdiagnosisof
type 1 or type 2 diabetes leaving 1 232 832 patients for
analysis (50.49% women).
Overall, we studied 3 773 585 patients contributing
24 079 172 person years, of whom 115 616 patients
(78 081 in the derivation cohort and 37 535 in the
validation cohort) had a new diagnosis of type 2
diabetes during follow-up. Table 1 compares the
characteristics of eligible patients in the derivation
andvalidation cohorts.Although this validation cohort
was drawn froman independent group of practices, the
baseline characteristics were very similar to those for
the derivation cohort. Overall, 898 461 patients
(23.81% of 3 773 585) had ethnicity recorded, and
122 736 (13.66%)of thesewere fromanon-white ethnic
group. Practices in areas where the proportion of
patients from a non-white ethnic group is higher
according to the 2001 census (such as London
(28.9%), East Midlands (6.5%), and West Midlands
(11.3%)) also have higher rates of completeness of
recording of ethnicity on the QResearch database
(40.1%, 21.4%, and 30.1% for the above areas).
Table 4 | Distribution of risk factors for type 2 diabetes by ethnic group in men and women in derivation cohort. Values are age standardised means and
proportions with 95% confidence intervals
Mean Townsend score* Mean body mass index
Percentage current
smokers
Percentage family
history of diabetes
Percentage treated
hypertension
Percentage
cardiovascular disease
at baseline
Women
White/not
recorded
−0.28 (−0.29 to −0.27) 25.47 (25.46 to 25.48) 26.26 (26.18 to 26.34) 11.32 (11.27 to 11.38) 6.20 (6.16 to 6.24) 2.79 (2.77 to 2.82)
Indian 1.03 (0.95 to 1.12) 25.43 (25.3 to 25.55) 6.90 (6.23 to 7.57) 32.05 (30.87 to 33.22) 8.16 (7.3 to 9.02) 3.35 (2.72 to 3.98)
Pakistani 2.40 (2.3 to 2.5) 27.21 (27.02 to 27.41) 5.25 (4.55 to 5.95) 25.69 (24.25 to 27.12) 6.78 (5.62 to 7.93) 3.38 (2.52 to 4.23)
Bangladeshi 4.59 (4.43 to 4.76) 25.63 (25.34 to 25.92) 8.19 (6.61 to 9.78) 20.31 (18.36 to 22.26) 7.67 (5.74 to 9.6) 2.41 (1.14 to 3.69)
Other Asian 2.06 (1.91 to 2.2) 24.65 (24.44 to 24.87) 9.53 (8.46 to 10.59) 25.21 (23.63 to 26.79) 8.27 (6.69 to 9.85) 1.73 (0.89 to 2.58)
Black Caribbean 3.63 (3.55 to 3.71) 27.73 (27.59 to 27.87) 18.30 (17.34 to 19.27) 32.63 (31.41 to 33.85) 16.59 (15.55 to 17.62) 3.19 (2.6 to 3.79)
Black African 4.00 (3.92 to 4.09) 28.44 (28.29 to 28.58) 4.61 (4.05 to 5.18) 18.51 (17.44 to 19.58) 13.43 (12.22 to 14.65) 2.24 (1.54 to 2.94)
Chinese 2.24 (2.08 to 2.41) 22.87 (22.68 to 23.06) 7.08 (5.86 to 8.3) 15.07 (13.53 to 16.61) 7.30 (5.62 to 8.99) 2.06 (1.06 to 3.05)
Other 2.95 (2.85 to 3.05) 26.27 (26.12 to 26.42) 19.06 (18.1 to 20.02) 23.46 (22.34 to 24.59) 10.49 (9.41 to 11.58) 3.47 (2.69 to 4.26)
Men
White/not
recorded
−0.20 (−0.2 to −0.19) 26.15 (26.15 to 26.16) 33.49 (33.4 to 33.58) 8.07 (8.02 to 8.12) 5.28 (5.25 to 5.32) 4.54 (4.5 to 4.57)
Indian 1.11 (1.03 to 1.19) 25.24 (25.14 to 25.34) 22.71 (21.6 to 23.81) 29.95 (28.78 to 31.11) 9.13 (8.28 to 9.98) 6.68 (5.91 to 7.44)
Pakistani 2.43 (2.34 to 2.52) 25.74 (25.6 to 25.87) 32.82 (31.29 to 34.35) 24.42 (23.12 to 25.72) 5.96 (5.05 to 6.87) 7.07 (6.09 to 8.06)
Bangladeshi 4.38 (4.21 to 4.54) 24.51 (24.31 to 24.7) 46.04 (43.16 to 48.92) 20.20 (18.28 to 22.12) 6.60 (4.94 to 8.26) 9.70 (7.76 to 11.65)
Other Asian 2.32 (2.17 to 2.47) 25.26 (25.1 to 25.43) 28.11 (26.16 to 30.07) 20.56 (19.05 to 22.07) 6.80 (5.39 to 8.21) 5.40 (4.04 to 6.76)
Black Caribbean 3.72 (3.63 to 3.82) 26.22 (26.09 to 26.35) 40.45 (38.99 to 41.91) 24.65 (23.38 to 25.92) 11.09 (10.17 to 12.01) 3.48 (2.9 to 4.06)
Black African 4.10 (4 to 4.2) 26.05 (25.92 to 26.18) 17.95 (16.76 to 19.14) 13.78 (12.73 to 14.83) 12.02 (10.7 to 13.33) 2.64 (1.85 to 3.43)
Chinese 2.40 (2.21 to 2.6) 23.80 (23.59 to 24.02) 26.63 (24.23 to 29.03) 13.16 (11.33 to 14.99) 4.12 (2.57 to 5.67) 2.26 (1.15 to 3.37)
Other 3.12 (3.02 to 3.22) 25.95 (25.82 to 26.08) 35.18 (33.82 to 36.54) 18.65 (17.57 to 19.73) 7.25 (6.29 to 8.21) 3.61 (2.88 to 4.35)
*Measure of material deprivation, ranging from −6 (most affluent) to 11 (most deprived).
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Patterns of missing data
Table 1 shows that 78.97% of women in the derivation
cohort had bodymass index recorded and 90.00% had
smoking status recorded; 78.03% had both body mass
index and smoking status recorded. For men, the
corresponding figures were 71.19%, 83.24%, and
70.12%. Overall, 22.97% of women and 29.88% of
men had either smoking or body mass index imputed
by multiple imputation (data were not imputed for
ethnicity—all patients with missing ethnicity were
treated as white/not recorded). Similar figures were
observed for men and women in the validation cohort,
where multiple imputation was also used.
Table 2 shows the characteristics ofmen andwomen
with complete data for smoking and body mass index
compared with those who had missing data. Women
withmissingdatahaddifferentpatternsof risk factors—
for example, womenwith complete data for bodymass
index were more likely to have a family history of
diabetes, to be recorded as current smokers, and to
have treated hypertension. They also had a lower
10 year observed risk of diabetes compared with
women with missing body mass index data. Women
with complete data for smoking were more likely to
have a diagnosis of cardiovascular disease, a diagnosis
of treated hypertension, and a family history of
diabetes. The 10 year observed risk of diabetes was
lower than for women whose smoking status was
missing. The pattern was similar for men for most risk
factors, except that the observed risks of diabetes were
lower among men with missing data.
Incidence of diabetes
Table 3 shows the crude and age standardised rates of
type 2 diabetes by sex, deprivation, and ethnicity in the
derivation cohort. The age standardised rates for the
white reference group were 4.13 (95% confidence
interval 4.08 to 4.17) per 1000 person years for women
and 5.31 (5.26 to 5.36) per 1000 person years for men.
The crude and age standardised incidence rates of type
2 diabetes in the derivation cohort varied widely
between ethnic groups, as shown in table 3. Age
standardised rates were significantly higher for men in
every ethnic group compared with the white reference
group, except for Chinese men. In women, age
standardised incidence rates were higher for every
group compared with the white reference group. The
highest age standardised rates were in South Asians,
and significant differences existed between the South
Asian groups. For example, the rate for Bangladeshi
women was 18.20 (12.93 to 23.47) per 1000 person
years and that for Bangladeshimenwas 19.34 (14.28 to
24.4) per 1000 person years. For Pakistanis, the
corresponding rates per 1000 person years were
11.19 (9.16 to 13.21) for women and 13.22 (11.24 to
15.21) for men.
We also found a marked difference in the age
standardised incidence rates of type 2 diabetes by
deprivation, with a more than twofold difference for
women when comparing the most deprived fifth (6.39
(6.25 to 6.54) per 1000 person years) with the most
affluent fifth (3.00 (2.93 to 3.08) per 1000 personyears).
A similar, but less steep gradientwas seen formen. The
rates seen in the validation cohort were similar to those
for the derivation cohort (data not shown).
Prevalence of risk factors by ethnicity
Table 4 shows the age standardised distribution of risk
factors across each of the main ethnic groups.
Substantial heterogeneity exists across the ethnic
groups for risk factors, and the distribution also differs
between men and women within ethnic groups. The
notable results include substantial differences in theage
standardised prevalence of smoking among men of
Bangladeshi (46.04%, 95% confidence interval 43.16%
to 48.92%), Caribbean (40.45%, 38.99% to 41.91%),
Pakistani (32.82%, 31.29% to 34.35%), white/not
recorded (33.49%, 33.40% to 33.58%), Chinese
(26.63%, 24.23% to 29.03%), Indian (22.71%, 21.60%
to 23.81%), and black African (17.95%, 16.76% to
19.14%) origin. Smoking rates were lower for women
in each ethnic group compared with men but varied
widely between women from different groups.
Treated hypertension was highest among black
Caribbean and black African men and women and
more than twice as high as that for the white reference
group.Recorded family history of diabeteswas highest
among black Caribbean women (32.63%, 31.41% to
Table 5 | Adjusted hazard ratios (95% confidence interval) for QDScore in derivation cohort (see
fig 1 for graphical representation of interaction terms)
Women Men
White/not recorded 1 1
Indian 1.710 (1.488 to 1.965) 1.929 (1.700 to 2.189)
Pakistani 2.152 (1.839 to 2.517) 2.538 (2.202 to 2.925)
Bangladeshi 4.071(3.242 to 5.112) 4.532 (3.673 to 5.591)
Other Asian 1.264 (0.943 to 1.695) 1.894 (1.492 to 2.404)
Black Caribbean 0.798 (0.695 to 0.915) 0.955 (0.824 to 1.108)
Black African 0.805 (0.661 to 0.979) 1.695 (1.421 to 2.023)
Chinese 1.961 (1.385 to 2.777) 1.414 (0.928 to 2.154)
Other 0.889 (0.738 to 1.07) 1.199 (1.005 to 1.431)
Age 1† 84.059 (68.345 to 103.384) 105.666 (89.11 to 125.3)
Age 2‡ 0.995 (0.9946 to 0.9954) 0.996 (0.9955 to 0.9962)
BMI 1§ 37.293 (31.118 to 44.694) 3.168 (3.000 to 3.345)
BMI 2¶ 0.934 (0.928 to 0.939) 0.832 (0.822 to 0.841)
Townsend score (per increase of 1
SD)
1.201 (1.188 to 1.214) 1.140 (1.129 to 1.152)
Family history of diabetes in a first
degree relative
2.358 (2.278 to 2.441) 2.725 (2.638 to 2.815)
Current smoker 1.268 (1.225 to 1.312) 1.249 (1.214 to 1.285)
Treated hypertension 1.787 (1.738 to 1.837) 1.711 (1.665 to 1.759)
Diagnosis of cardiovascular disease 1.458 (1.402 to 1.517) 1.500 (1.455 to 1.546)
Current treatment with
corticosteroids
1.412 (1.339 to 1.489) 1.259 (1.181 to 1.342)
Model also included fractional polynomial terms for age and body mass index and interactions between age
terms and body mass index terms, age terms and family history of diabetes, and age terms and smoking status
(see fig 1).
BMI=body mass index.
†Women: age 1=(age/10)½; men: age 1=log(age/10).
‡Women: age 2=(age/10)3; men: age 2=(age/10)3.
§Women: BMI 1=(BMI/10); men: BMI 1=(BMI /10)2.
¶Women: BMI 2=(BMI/10)3; men: BMI 2=(BMI /10)3.
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33.85%) and Indian men (29.95%, 28.78% to 31.11%),
which was more than three times that for the white
reference group who had the lowest rates (11.32%,
11.27% to 11.38% for women and 8.07%, 8.02% to
8.12% for men).
Bangladeshi men and women had the highest age
standardised mean deprivation scores, followed by
those of black African and black Caribbean origin.
Indians and the white reference group had the lowest
mean deprivation scores, as shown in table 4.
The highest mean bodymass index was seen among
black African women (age standardised mean 28.44,
28.29 to 28.58) compared with 25.47 (25.46 to 25.48)
for women in the white reference group. The lowest
value was in Chinese women (age standardised mean
22.87, 22.68 to 23.06). Similar patterns, although
slightly less marked, were seen for men across the
ethnic groups. Finally, 9.70% (7.76% to 11.65%) of
Bangladeshi men had a recorded diagnosis of cardio-
vascular disease at baseline,whichwasmore than twice
that formen in thewhite referencegroup (4.54%,4.50%
to 4.57%) and more than four times that found in
Chinese men (2.26%, 1.15% to 3.37%).
Model development
Table 5 shows the results of theCox regression analysis
for the QDScore. After adjustment for all other
variables in the model, we found significant associa-
tions with risk of type 2 diabetes in both men and
women for age, body mass index, family history of
diabetes, smoking status, treated hypertension, use of
corticosteroids, diagnosed cardiovascular disease,
social deprivation, and ethnicity. We therefore
included these variables in the final model and risk
prediction algorithm.
We found significant heterogeneity of risk of type 2
diabetes by ethnic group compared with the white
reference population, having adjusted for age, body
mass index, deprivation, family history of diabetes,
smoking status, treated hypertension, diagnosed
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Fig 1 | Graphical representation of age interactions for men and women for risk of type 2 diabetes
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cardiovascular disease, use of corticosteroids, and
diagnosed cardiovascular disease, as shown in table 4.
For example, amongBangladeshis, the adjustedhazard
ratio forwomenwas4.07 (95%confidence interval3.24
to 5.11) and that for men was 4.53 (3.67 to 5.59). These
were significantly higher than the increased hazard
ratios in Pakistani women andmen (2.15, 1.84 to 2.52;
and 2.54, 2.20 to 2.93). Both Pakistani andBangladeshi
men had significantly higher hazard ratios than Indian
men. Black African men and Chinese women had
increased risks comparedwith thecorrespondingwhite
reference group. The only groups to have significantly
lower risks than the white reference group were black
African women (0.81, 0.66 to 0.98) and black
Caribbean women (0.80, 0.70 to 0.92).
The fractional polynomial terms selected for inclu-
sion in themodelwere as follows. For age inwomen the
two termswere (age/10)½ and (age/10)3. For bodymass
index in women, the two terms were (bmi/10) and
(bmi/10)3. Formen, the twoage termswere log(age/10)
and (age/10)3 and the two terms for body mass index
were (bmi/10)2 and (bmi/10)3. Figure 1 shows the
estimated adjusted hazard ratios by age and bodymass
index for these fractional polynomial terms inmen and
women.
We identified significant interactions between age
and body mass index, age and family history of
diabetes, and age and smoking status. We therefore
included these interactions in the final model, and the
general direction of the effects was that body mass
index and family history of diabetes tended to have a
greater impact on risk of diabetes at younger ages, as
shown in fig 1. Smoking had a more complex relation
with age; the risk peaked in middle age for both men
and women.
In a comparison of models, the median Bayes
information criterion for women for our final model
(model A) was 875 203, for the model without
deprivation and ethnicity (model B) it was 876 400,
for the model without ethnicity (model C) it was
875 270, and for themodelwithout deprivation (model
D) it was 876 198, indicating that the model that
incorporated both ethnicity and deprivation was
superior to the other three. Formen, the corresponding
figures were 1 086 755, 1 087 745, 1 087 034, and
1 087 369, similarly supporting the inclusion of both
ethnicity and deprivation into the final model.
Calibration and discrimination of QDScore
Table 6 shows the results for the validation statistics for
men and women after application of the QDScore and
theCambridge risk score in the validation dataset. The
QDScore shows higher levels of discrimination than
the Cambridge risk score. For example, in women the
D statistic for the QDScore was 2.11 (95% confidence
interval 2.08 to 2.14) comparedwith 1.88 (1.85 to 1.91)
with theCambridge risk score; a 0.1 difference in theD
statistic indicates an important difference in prognostic
separation between two risk algorithms. 41 The
QDScore explained a higher proportion of the
variation—it explained 51.53% of the variation in
women and 48.16% of that inmen. The corresponding
values for the Cambridge risk score were 45.77% and
41.82%. The Brier score, however, was slightly lower
for the Cambridge risk score in both men and women.
Figure 2 compares the mean predicted scores from
theQDScore with the observed risks at 10 years within
each 10th of predicted risk in order to assess the
calibration of the model in the validation sample. The
close correspondence betweenpredicted andobserved
10 year risks within each model 10th suggests that the
modelwaswell calibrated. For example, in the top 10th
of risk, the mean predicted risk was 18.31% (95%
confidence interval 18.24% to 18.38%) in women and
the observed risk was 18.82% (18.39% to 19.26%).
The ratio of predicted to observed risk in this tenth
was 0.97, indicating almost perfect calibration (a ratio
of 1 indicates perfect calibration—that is, no under-
prediction or over-prediction). We found similar
results for men, with a ratio of 0.99 in the top 10th of
predicted risk.
Predictions with age, sex, deprivation, and ethnicity
Table 7 shows the percentages of men and women in
the validation dataset with a 10 year predicted risk of
being diagnosed as having type 2 diabetes according to
a range of thresholds and by age band. For example, at
the 10% threshold, 10.60% of women and 15.06% of
men had a 10% or higher predicted risk of being
diagnosed as having type 2 diabetes over 10 years. This
varied markedly by age such that 21.43% of women
aged 55-59 and 30.99% of women aged 65-69 had a
10%or greater risk of being diagnosed as having type 2
diabetes over 10 years. The corresponding figures for
men were 33.28% and 44.08%.
Tables8and9 showthe10year riskof type2diabetes
amongmen and women of different ethnic groups and
for those living in themost deprived and affluent areas.
For example, 33.83% of Bangladeshi women had a
10 year risk of being diagnosed as having diabetes of
10% or more compared with 10.48% of women in the
white reference group, and 15.03% of women in the
most deprived fifth had a 10% or higher risk of
Table 6 | Validation statistics for QDScore and Cambridge risk score in validation cohort. Values
are mean (95% confidence interval)
QDScore Cambridge risk score
Women
R squared* 51.53 (50.90 to 52.16) 45.77 (45.08 to 46.46)
D statistic* 2.110 (2.084 to 2.137) 1.880 (1.854 to 1.906)
ROC statistic* 0.853 (0.850 to 0.856) 0.813 (0.810 to 0.817)
Brier score† 0.058 (0.055 to 0.060) 0.044 (0.041 to 0.046)
Men
R squared* 48.16 (47.52 to 48.80) 41.82 (41.19 to 42.51)
D statistic* 1.973 (1.947 to 1.998) 1.735 (1.710 to 1.760)
ROC statistic* 0.834 (0.831 to 0.836) 0.801 (0.798 to 0.804)
Brier score† 0.078 (0.075 to 0.080) 0.055 (0.052 to 0.057)
ROC=receiver operator curve.
*Higher values indicate better discrimination.
†Lower values indicate better performance.
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developing diabetes over the next 10 years compared
with 6.52% of women in the most affluent fifth. The
difference between affluent and deprived fifths is more
marked for women than for men; the corresponding
figures are 15.65% for men in the most deprived fifth
and 13.21% for men in the most affluent fifth.
Overall, almost half (15 545/32 450; 47.9%) of cases
of diabetes occurred in the top 10th of the distribution
(risk of ≥10.38%) and almost 70% (22 476/32 450)
occurred in the top fifth (risk of ≥5.98%).
DISCUSSION
TheQDScore is the first diabetes prediction algorithm
developed and validated by using routinely collected
data to predict the 10 year risk of developing type 2
diabetes. Our final model includes both deprivation
and ethnicity as well as age, sex, smoking, treated
hypertension, body mass index, family history of
diabetes, current treatment with corticosteroids, and
previous diagnosis of cardiovascular disease. The
QDScore does not require any laboratory testing or
clinical measurements and so can be used in many
settings, including by individualmembers of the public
who have access to a computer. This risk prediction
toolmightbeused to identify andproactively intervene
in people identified as having an increased risk. This
algorithm, like other algorithms that predict cardio-
vascular disease,30 44 relies on routinely collected data
and has the advantage that it is readily implementable.
Furthermore, it is likely to reduce, rather than
exacerbate, widespread and persistent health inequal-
ities. TheQDScore performedwell comparedwith the
Cambridge risk score. Assuming that the effectiveness
and cost effectiveness of suitable interventions shown
in randomised controlled trials extend to unselected
patients from primary care,7-10 the QDScore could be
used to identify patients at increased risk of diabetes
who might benefit from interventions to reduce their
risk.
The traditional method for identifying patients at
increased risk of type 2 diabetes has involved the
detection of impaired glucose tolerance requiring an
inconvenient andexpensiveoral glucose tolerance test.
Targeted screening of higher risk groups has been
proposed as a more cost effective solution,45 as the risk
factors for diabetes and cardiovascular outcomes
overlap considerably.46 Less expensive and more
practical methods of identifying patients at increased
risk are needed; these should ideally be based on
models developed from contemporaneous data in
ethnically and socioeconomically diverse populations
obtained fromtheclinical setting inwhich thesemodels
will subsequently be applied. Simple clinical models
using readily available data can offer similar discrimi-
nation to more complex models using laboratory data
or biomarkers,17 and clinical models that do not need
clinical measurements may have a further utility in
settings where clinical measurements are not available
or are too costly to collect.47 UK datasets derived from
familypractices have the advantageof having large and
broadly representative populations with historical data
tracking back well over a decade in most practices.
These databases also contain data on many of the key
variables known to be associated with risk of type 2
diabetes, such as age, sex, ethnicity,2 8 48 4 9
smoking,16 24 50 body mass index,16 17 28 48 family history
of diabetes,16 17 28 48 49 treated hypertension,16 17 current
use of corticosteroids,16 and social deprivation.51
Deprivation is not only strongly associated with
increased prevalence of diabetes and diabetes related
risk factors suchasdiet, obesity, and smokingbut is also
associated with poorer outcomes and intermediate
measures such as achievement of lipid targets.51
Strengths and weakness
Sampling and generalisability
Particular strengths of our study are the use of a large
representative population from a validated database,
our prospective cohort design, and the substantial
numbers of patients with self assigned ethnicity for use
in the analysis.Wehavemodelled interactionswith age
and included these in the final model, so our algorithm
takes account of the differential effect of three key
variables (family history of diabetes, body mass index,
and smoking) at different ages.
Another important strength of the QDScore is that
all the variables used in the algorithm will either be
known to an individual patient or are collected as part
of routine clinical practice and recorded within an
individual patient’s primary healthcare record in most
economicallydevelopedcountries.Thismeans that the
algorithm can be used by patients for self assessment in
a web based calculator (www.qdscore.org) similar to
the one available for self assessment of cardiovascular
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disease (www.qrisk.org). Alternatively, it can be
implemented within clinical computer systems used
in primary care and be used to stratify the practice
population (aged 25-79) for risk on a continuing basis
without the need formanual entry of data.Althoughno
widely agreed thresholds for classification of patients at
“high risk” exist, the QDScore could act as a basis for a
systematic programme to identify patients at increased
risk for intervention or to aid earlier diagnosis.
Importantly, appropriate weighting for ethnicity and
social deprivation should furthermore help to avoid
widening health inequalities associated with introduc-
tion of systematic programmes of disease prevention
activities.
Limitations compared with an ideal study
Despite its strengths, our study has limitations com-
pared with an ideal study. In the ideal study, a large
representative and tightly phenotyped primary care
cohort would be assembled and followed longitudin-
ally over the course of a decade. No patients would be
lost to follow-up, and all patients would be subjected to
repeated oral glucose tolerance tests throughout
follow-up to confirm or refute the diagnosis of type 2
diabetes. Although such a study would be very
welcome, it would take at least 15 years to carry out
and report, it would beunlikely to be feasible in routine
primary care, and calibration would be inaccurate in
more socially and ethnically diverse populations with
different baseline risks. Our study offers a practical
alternative approach, which can be implemented into
primary care in a cost effectivemanner,while acknowl-
edging the potential biases and their likely impact.
Potential sources of misclassification, bias, and
confounding
One limitation of our study is that the main outcome
was type 2 diabetes diagnosed by a clinician and
recorded on the clinical computer system. The out-
comewas not formally validated, andwehave not used
the results of laboratory tests to confirm the diagnosis.
However, this diagnosis would be unlikely to be
recorded if the patient did not have diabetes—other
studies of similar databases have shown good levels of
accuracy for common chronic conditions, especially
those that are now included in the UK quality and
outcomes framework.52
Undiagnosed diabetes is a well recognised problem
and is not specifically considered by our study. It is
estimated to affect approximately 3%of the population
according to the health survey for England.53 Some
evidence suggests that South Asian women are more
likely to have undiagnosed diabetes than are the
general population, so our hazard ratios might
Table 7 | Percentage of patients in validation dataset with 10 year predicted risk of type 2 diabetes from QDScore of ≥10%,
≥15%, ≥20%, ≥30%, ≥40%, and ≥50% by age and sex
Age band (years)
Predicted 10 year risk score for type 2 diabetes
≥10% ≥15% ≥20% ≥30% ≥40% ≥50%
Women
25-29 0.34 0.10 0.02 0.00 0.00 0.00
30-34 0.93 0.36 0.12 0.02 0.01 0.00
35-39 2.40 1.03 0.47 0.07 0.02 0.01
40-44 5.15 2.19 1.09 0.29 0.09 0.03
45-49 9.52 4.29 2.32 0.70 0.21 0.08
50-54 15.24 7.42 4.00 1.31 0.47 0.17
55-59 21.43 11.39 6.19 2.14 0.81 0.28
60-64 27.79 15.20 8.63 3.22 1.31 0.52
65-69 30.99 16.49 9.20 3.03 1.17 0.45
70-74 30.70 15.68 8.25 2.62 0.89 0.29
75-79 27.75 12.38 5.94 1.71 0.50 0.17
Total 10.60 5.28 2.82 0.92 0.33 0.12
Men
25-29 0.54 0.26 0.15 0.05 0.02 0.01
30-34 1.62 0.67 0.36 0.14 0.05 0.02
35-39 4.17 1.77 0.94 0.39 0.13 0.04
40-44 8.67 4.11 2.08 0.76 0.31 0.10
45-49 15.29 7.46 3.87 1.39 0.58 0.24
50-54 23.84 12.46 6.77 2.39 1.01 0.43
55-59 33.28 17.82 10.21 3.83 1.60 0.63
60-64 40.41 22.83 13.32 4.74 1.89 0.79
65-69 44.08 24.99 14.40 5.03 1.98 0.79
70-74 44.00 23.58 12.94 4.14 1.43 0.50
75-79 39.54 18.86 9.23 2.57 0.73 0.22
Total 15.06 7.89 4.36 1.53 0.60 0.23
RESEARCH
page 10 of 15 BMJ | ONLINE FIRST | bmj.com
underestimate the association for these patients.54 The
risk factors for diagnosed diabetes are very similar to
those for undiagnosed diabetes.55 Nevertheless, most
previously undiagnosed cases are likely to have been
included in the identified high risk groups and to have
been picked up by systematic further evaluation,
because risk stratification improves yield.55
Our study might have been affected by recording
bias if a patient diagnosed as having diabetes was not
recorded as having diabetes on the practice computer
system. The recording bias could lead to misclassifica-
tion of patients either at baseline or at follow-up and is
part of the justification for having a targeted approach.
Any misclassification bias of the outcome, if non-
differential, would tend to bias the hazard ratio towards
one and reduce discrimination.
Recordingof apositive familyhistoryofdiabeteswas
higher among women than among men. This could
reflect recording bias or information biases resulting
from differences in family history among women or
greater opportunity for the information to be recorded
as women tend to have higher consultation rates than
men. Our study might have been affected by an
ascertainment bias caused by differential testing of
patients for diabetes by ethnic group or in those with
specific risk factors.This could lead to increased ratesof
detection among patients with specific risk factors,
including South Asian ethnicity, a family history of
diabetes, or obesity—increased awareness among
patients and clinicians might increase the likelihood
of testing and therefore of clinical diagnosis. The effect
of this would be to increase the apparent strength of the
association between the risk factors and incident
diabetes. Nonetheless, our hazard ratios for the risk
factors in the model are generally of a similar
magnitude to those found in other studies which tested
for diabetes in the entire study cohort.56 In addition, the
assessment and recording of these factors in clinical
practice is becoming increasingly routine and com-
plete, so limiting the effect of this potential bias.
Another potential limitation of our study is that 25%
of patients had missing values for either body mass
index or smoking status. Patients with complete data
tended to have different risks than those with missing
data. We therefore used the technique of multiple
imputation to substitute missing values for smoking
and body mass index, rather than excluding these
patients, as this is a less biased approach that makes the
most efficient use of available data. The differences in
risk factors and in the observed risks of diabetes
between patients with and without missing data
support the use of multiple imputation rather than a
complete case analysis.
Variables included in final model
Clinicians had recorded our predictor variables on the
clinical computer system before the diagnosis of type 2
diabetes, so these will not have been subject to recall
bias. We have used the entire population registered
with the QResearch practices contributing to the
database from England andWales. Consequently, the
population isunlikely tobeaffectedby selectionbias, in
contrast to the selection bias that inevitably occurs
when patients are individually recruited to clinical
cohorts or clinical trials.57 We have included a proxy
measure of material deprivation, the Townsend
score,58 which is based on the patient’s postcode at
the level of the output area (corresponding to around
Table 8 | Percentage of patients in validation dataset with 10 year predicted risk of type 2 diabetes from QDScore of ≥10%,
≥15%, ≥20%, ≥30%, ≥40%, and ≥50% by ethnicity and sex
Ethnic group
Predicted 10 year risk score for type 2 diabetes
≥10% ≥15% ≥20% ≥30% ≥40% ≥50%
Women
White/not recorded 10.48 5.15 2.70 0.85 0.29 0.10
Indian 14.56 9.35 5.86 2.72 1.29 0.72
Pakistani 26.36 18.16 12.91 6.43 3.36 1.77
Bangladeshi 33.83 25.07 18.72 10.92 6.35 3.71
Other Asian 6.45 3.77 2.20 1.05 0.47 0.16
Black Caribbean 17.10 11.09 7.45 2.93 1.41 0.49
Black African 8.96 4.81 2.68 0.74 0.27 0.08
Chinese 4.32 2.58 1.46 0.28 0.00 0.00
Other 7.90 4.26 2.39 0.74 0.29 0.13
Men
White/not recorded 14.93 7.72 4.21 1.43 0.54 0.20
Indian 20.52 13.07 8.55 4.21 2.09 1.20
Pakistani 27.21 19.32 13.93 7.42 3.68 2.19
Bangladeshi 33.26 24.52 19.23 11.58 7.10 4.26
Other Asian 14.96 9.75 6.30 2.71 1.35 0.74
Black Caribbean 19.31 11.98 7.72 3.47 1.63 0.79
Black African 16.10 9.83 6.15 3.24 1.83 1.02
Chinese 7.59 3.69 2.11 0.84 0.42 0.11
Other 9.91 6.00 3.69 1.72 0.80 0.27
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150 households) and is a composite score comprising
lack of a car, unemployment, over-crowding, and non-
home ownership. Some people living within an output
area will not be typical of the other residents, resulting
in some misclassification. Deprivation is likely to be
associated with other factors known to increase risk of
diabetes, such as poor diet, lack of exercise, and
increased alcohol intake, and so will account at least in
part for some of the effect of these factors.51 Lastly, we
included treated hypertension as a predictor as both
blood pressure and some antihypertensive drugs (such
as thiazides) may have contributed to the increased
hazard ratios associated with this variable.
Self assigned ethnicity
We used self assigned ethnicity in our analyses, as
reported by patients to their general practices, which
has advantages over analyses in which ethnicity is
assigned by an informant rather than the patient, is
imputed geographically, or is related to country of
birth. The last of these is particularly problematic as
increasing numbers of people from minority ethnic
groups are now being born in the UK. We have also
been able to disaggregate the South Asian groups and
report on them separately, which answers concerns
with studies that tend to combine them into one group
when they differ in risk factor exposure, disease rates,
and outcomes. One important limitation is that only
one quarter of patients overall had self assigned
ethnicity recorded. Among those with a recorded
value, 13.66%were recorded as from aminority ethnic
group, which is higher than the estimated figure for
2006 based on the 2001 census, indicating over-
representation of practices from ethnically diverse
areas, that practices in ethnicallydiverse areas aremore
likely to record ethnicity, or most likely a combination
of both.Wehave assumed thatwhere patients have self
assigned ethnicity recorded (as Bangladeshi, for
example) this is accurate and the patient was indeed
Bangladeshi. Where patients did not have ethnicity
recorded, we have assumed they were white. Any
misclassification arising from these assumptions is
most likely to affect the reference category of “white or
not recorded,” but because of the mix of the popula-
tions of England and Wales, less than 7% of such
patients are likely to be from a non-white ethnic group.
This misclassification error is likely to be non-
differential and if so will tend to underestimate the
relative effect of ethnicity on risk of type 2 diabetes
rather than generating spurious associations. Misclas-
sification would also tend to reduce levels of discrimi-
nation and underestimate risk in some misclassified
patients. We restricted all values of variables in the
model to those that had been recorded in the person’s
electronic healthcare record before the diagnosis of
type 2 diabetes (or before censoring for those who did
notdevelop type2diabetes) inorder to avoid recording
bias.
Validation of risk prediction algorithm
We validated the QDScore in a separate sample of
general practices from those used to develop the score.
The QDScore has good discrimination (that is, ability
to separate out people who did and those who did not
subsequently develop type 2 diabetes) and explains
approximately 50% of the total variation in times to
diagnosis of diabetes. The D statistic, which is a
measure of discrimination appropriate for survival
typedata,washigher than inour cardiovasculardisease
algorithm and that reported in some other studies.30 42
This increases the likelihood that the algorithm will
more accurately predict risk for an individual patient.
An important limitation of our validation is that a
degree of over-optimism could exist as, although we
have used a completely physically discrete set of
general practices for the validation, these practices use
the same clinical computer system (EMIS) as those
used to derive the algorithm. This system is, however,
currently in use in 60% of UK general practices, so the
diabetes clinical risk algorithm is at least likely to
performwell for well over half of the UK’s population.
A more stringent test of performance would involve
practices using a different clinical computer system;
however, recording of ethnicity in other general
Table 9 | Percentage of patients in validation dataset with 10 year predicted risk of diabetes from QDScore of ≥10%, ≥15%,
≥20%, ≥30%, ≥40%, and ≥50% by deprivation fifth and sex
Townsend fifth
Predicted 10 year risk score for type 2 diabetes
≥10% ≥15% ≥20% ≥30% ≥40% ≥50%
Women
1 (most affluent) 6.52 2.64 1.24 0.28 0.09 0.02
2 8.29 3.61 1.71 0.43 0.13 0.03
3 10.83 5.05 2.49 0.72 0.22 0.08
4 12.94 6.76 3.61 1.21 0.40 0.14
5 (most deprived) 15.03 8.74 5.26 2.03 0.85 0.34
Men
1 (most affluent) 13.21 6.17 3.07 0.93 0.32 0.10
2 14.80 7.30 3.71 1.21 0.40 0.13
3 15.99 8.31 4.45 1.48 0.53 0.19
4 15.91 8.73 4.95 1.78 0.74 0.29
5 (most deprived) 15.65 9.08 5.65 2.27 1.01 0.46
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practice databases is at present likely to be too low for a
meaningful comparison, asEMIShasmorepractices in
ethnically diverse areas. Nonetheless, our previous
algorithm for cardiovascular disease, developed with
similar methods and the same database,44 has subse-
quently performed well on another database contain-
ing primary care data from practices using a different
clinical computer system.23
Heterogeneity of risk factors and risk of type 2 diabetes
Our study has good face validity, as the prevalence of
established risk factors reported here corresponds to
that reported elsewhere.59 We found a significant
heterogeneity of risk factors, incidence rates, and
hazard ratios for type 2 diabetes across the ethnic
groups. The high prevalence of a recorded family
history among South Asians may reflect a true
increased rate or could be due to differences in what
constitutes a first degree relative (for example, cousins
may be regarded as siblings). Of particular interest are
the significant differences in hazard ratios between the
SouthAsian groups; Bangladeshimen andwomenhad
higher risks than Pakistanis, who in turn had higher
risks than Indians.
Comparison with other diabetes risk scores
Routinely collected data from electronic primary
healthcare records have been used to develop other
risk prediction algorithms. For example, data from
531 general practices was used to develop and validate
the QRISK2 cardiovascular disease risk tool, which is
being implemented in clinical settings in the UK.30 44
The Cambridge diabetes risk score was developed by
combining data from two different general practice
samples. The first sample consisted of half of the
participants recruited for the study, in which patients
were tested for diabetes by using an oral glucose
tolerance test in one general practice in Cambridge-
shire. The second sample consisted of half of the
incident cases of diabetes identified over a 12 month
period from 41 practices in the south of England.16 20
The combined data from a total of 650 patients,
including 126 cases of diabetes, were then used to
derive a risk score designed to identify patients with
undiagnosed diabetes at a point in time.16 20 The score
was thenvalidated in the remaininghalf of the recruited
patients from the practice in Cambridgeshire. The
Cambridge risk score has since been applied to a
prospective cohort to estimate the risk of incident
diabetes in 25 000 people from Norfolk.60
One advantage of the QDScore is the use of a larger
andmore representative cohort,which ismore likely to
generalise to the UK. Another advantage is the
inclusion of both deprivation and self assigned
ethnicity, which are independently associated with
risk of incident diabetes; this is likely to help with the
problems identifiedwith theCambridge risk score in its
performance in ethnically diverse populations.20 The
QDScore explained significantlymore of the variation
and had improved discrimination compared with the
Cambridge risk score. Overall, almost half (15 545/
32 450; 47.9%) of cases of diabetes occurred in the top
10th of the distribution and almost 70% (22 476/32 450
) occurred in the top fifth based on the diabetes clinical
risk score. This compared with 27.3% and 50% for the
top 10th and fifth reported in the Cambridge risk score
paper.16 We cannot determine the calibration of the
Cambridge risk score, as it does not give a measure of
absolute risk over a given time period.
Our validation has some limitations. Although our
validation cohort consisted of separate practices and
patients, the practices used the same clinical computer
system (EMIS) and so there may be a degree of over-
optimism. Future studies could test the performance of
the QDScore in other databases based on practices
using a different clinical computer systemor in cohorts
in which formal diagnostic testing may be possible.
We did not do comparisons with other prospective
studies that have developed a risk prediction score for
which laboratory tests are needed (such as measure-
ment of high density lipoprotein cholesterol,17 49
triglycerides,17 49 or fasting glucose17) or that have
included variables which are difficult to measure
consistently and reliably such as waist circumference
and which, unlike body mass index, are not routinely
recorded in general practice.18 49 Other diabetes scores
have been developedwithin specific ethnic groups (for
example,MexicanAmericans,48 JapaneseAmericans28
), butwe have too few patients in theUK in these ethnic
groups to allow a meaningful comparison to be made
within this analysis.Nonetheless, our receiver operator
curve statistic of 0.85 for women and 0.83 for men is
substantially higher than those in many studies, which
have reported values ranging between 0.71 and
0.8016 27 28 49 60; it is very comparable to the three studies
reporting the highest receiver operator curve statistics,
with values of 0.85 and 0.86.17 18 48 Lastly, althoughdata
on fasting and random glucose are recorded to some
extent within primary care electronic health
records,25 61 we did not think that these were suitable
WHAT IS ALREADY KNOWN ON THIS TOPIC
Good evidence shows that behavioural or pharmacological interventions can prevent type 2
diabetes in up to two thirds of patients at high risk and that early diagnosis is likely to improve
outcomes
In 2009 the Department of Health will start a major vascular screening programme, which
includes identificationandmanagementof patients at high riskof diabetes for preventive care
No widely accepted and validated risk prediction score takes account of both social
deprivation and ethnicity and can be applied in primary care in the UK
WHAT THIS STUDY ADDS
TheQDScore isanewriskpredictionalgorithmfor type2diabetesdeveloped inavery largeand
unselected family practice derived population, with appropriate weightings for ethnicity and
social deprivation
The final algorithm includes self assigned ethnicity, age, sex, body mass index, smoking
status, family history of diabetes, Townsend deprivation score, treated hypertension,
cardiovascular disease, and current use of corticosteroids
The performance of the QDScore in an independent sample of practices showed good
discrimination and calibration
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for use in a prediction score, as they are the basis for
makingdiagnosesof diabetes in this context rather than
being recorded in a representative sample of patients at
baseline. In addition, we were interested to develop a
score that did not require laboratory measurements.
Conclusions
Simple risk algorithms have performed well in
comparison with more complex clinical evaluations
in studies of diabetes and cardiovascular disease.17 47
This algorithm to predict risk of type 2 diabetes has the
uniqueadvantageof includingbothethnicity andsocial
deprivation, can be derived without laboratory mea-
surements, and thus is suitable for use both in clinical
settings and for self assessment. TheQDScore could be
used to identify patients at high risk of diabetes who
might benefit from interventions to reduce their risk.
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